Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT03738423 · TERMINATED
Trial details
- NCT number
- NCT03738423
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2020-03-13
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.